Video and multimedia from Aldevron
Learn more about our company, its mission, purpose and values, as well as get to know the people who have made the company what it is today.
Plasmid DNA Technology
Aldevron has been perfecting plasmid DNA production for more than 20 years, using proprietary technology to manufacture DNA for a wide range of research, preclinical, clinical, and diagnostic applications. Watch this video to learn how plasmid DNA is used in gene and cell therapies and more.
Aldevron Sponsors FRAXA Biotech Games
Aldevron was an inaugural sponsor of the FRAXA Biotech Games and continued its involvement in 2019 to support the FRAXA Research Foundation. The foundation funds research into Fragile X, the most common inherited cause of autism. Jessica Haugen of Thompson, ND, is a board member for FRAXA, and her son, Larry, was diagnosed with Fragile X at 18 months. She and Larry visited Aldevron to discuss the disease and meet company employees.
Aldevron Expansion Plans
Aldevron Chief Operating Officer Henry Hebel discusses Aldevron's new facility and the company's expansion plans at BIO International in Boston. Video provided by Pharma's Almanac TV.
Aldevron and Accelerating Innovation for Gene Therapy
Michelle Berg, President of Aldevron's GMP Nucleic Acids Business Unit, expands on company service offerings, future plans and their effect on innovation in gene therapy, while attending BIO International in Boston. Video provided by Pharma's Almanac TV.
Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus
Phase one construction will begin in August 2019. Upon completion of the campus, the annual capacity will exceed $1 billion of plasmid DNA, RNA, gene editing enzymes, and other biologics.